- Catalog Home
- » Phake: the deadly world of falsified and substandard medicines
Phake: the deadly world of falsified and substandard medicines
Author
Language
English
Description
Loading Description...
Table of Contents
From the Book
Preface --
Introduction --
Part I. The deadly world of dangerous medicines --
1. Historical examples of dangerous medicines --
China-U.S. Heparin scandal --
DEG: the sweet, syrupy killer --
Tuberculosis: poor-quality medicines contribute to drug resistance --
2. Understanding the problem --
What are dangerous drugs? --
Guessing the value of the fake-drug market --
The worsening state of dangerous medicines: a growing problem --
When cheap becomes expensive: why quality matters --
The importance of good manufacturing practice --
The crucial role of medical regulatory authorities --
How diversion can lead to counterfeiting --
3. Overview of research findings and possible solutions --
Identifying source and target --
Field research --
What can be done? --
Part II. Dangerous drug problems by location --
4. Africa -- Counterfeit malaria treatments and growing drug resistance --
Nigeria's medical regulatory authority steps up --
Everyone blames foreigners --
NAFDAC's new leadership --
Deploying new technology --
Has Orhii improved drug quality? --
A shift to local production --
Combating corruption --
Political will --
Changing buying behavior takes time --
Fraud and theft: an entry point for fake drugs from East Africa to Nigeria --
East African investigations --
Diverted donor drugs in Togo --
On the trail of stolen medicines --
Post Hartcourt and Onitsha --
5. India --
Tracking the counterfeiters --
Major manufacturers --
Fake-market size --
Drug production oversight: the Ranbaxy saga --
Whistleblowers and informants --
Indian exports to Africa --
International networks --
Why India should favor more international cooperation --
6. China --
Discovering the source --
Locating the (legal) source of substandard ingredients --
The battle against counterfeiters in China --
Waking the dragon: China begins to make an effort --
Made in India, faked in China -- The way forward in China --
7. Middle East --
The vicious cycle begins: Iraq --
Dangerous dealings: fakes infiltrate the markets --
The smuggling ring expands: Syria and Jordan --
Middle Eastern governments confront the counterfeit trade --
Looking ahead: more challenges to come --
Conclusion --
8. Other emerging markets --
Russia --
Latin America --
Southeast Asia --
Turkey --
Conclusion --
9. The online drug market --
The case for universal jurisdiction --
Internet pharmacies: are the benefits worth the costs? --
A study of credentials --
Credentialed sites are safe, but buyer beware (of junk mail) --
Part III. Drug-quality assessments --
10, Factors to consider for research --
Bringing a medicine to market --
Testing drugs for quality --
The minilab --
Handheld spectrometers --
What we procured from where --
11. Results: what we found --
More detailed analysis with more limited datasets --
The role of registration --
Variability analysis --
Survey of pharmacists --
12. Results broken down for Africa, India, and other markets --
Africa --
India --
Remaining cities tested --
13. Interpreting and discussing the results and their relevance --
Comparing percent API in various failures: breakdowns of the data --
What role does price play in quality? --
Further price analysis --
African price data --
Regulation, income, and literacy rate: an analysis of possible confounding variables --
Regulation --
Macrolevel analysis --
Counterfeit or substandard? --
Part IV. The way forward --
14. Developing medical regulatory authorities: the U.S. FDA as a case study --
Why an FDA? It's all about economics --
The creation of the FDA --
Drug regulation and the market's decisions --
The Massengill massacre --
The FDA's expanding authority --
The FDA and China --
Challenges to MRA development --
Limits to international assistance --
Priorities for MRAs in developing countries --
The MRA role in protection through registration --
Registration is a means, not the end --
Challenges to implementation --
15. International cooperation against criminals and the lethal trade in fake medicines --
Counterfeit medicines and international law --
The extent and effects of medicine counterfeiting --
Goals, doctrines, and proposals for a counterfeit medicines treaty --
Counterfeiting crimes are widespread and systematic --
WHO authority to negotiate a treaty against medicine counterfeiting --
A call to action --
Final thoughts and recent developments --
16. A market for products of varying quality and the intellectual property debate --
Approaches to GMP --
In the end, it is all about endogenous growth.
Excerpt
Loading Excerpt...
Author Notes
Loading Author Notes...
More Details
ISBN
9780844772332
084477233
084477233
Reviews from GoodReads
Loading GoodReads Reviews.
Staff View
Loading Staff View.